Search

everythinglearnresearchcommunity

for

Search:↓

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

PLD is an effective and safer alternative for treating breast cancer.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

GnRH treatment can reduce breast cancer cell invasion.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Compounds from Etlingera alba may help treat Triple Negative Breast Cancer.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

Radiotherapy affects mitochondrial-related genes in metastatic breast cancer cells.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

A rare case of hair loss was linked to breast cancer spreading to the scalp, but treatment was effective.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

The herbal hair oil effectively promotes hair growth, reduces dandruff, and enhances hair shine with minimal side effects.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.